US2017260232A1PendingUtilityA1

Tubulysin compounds, methods of making and use

64
Assignee: BRISTOL MYERS SQUIBB COPriority: Feb 14, 2013Filed: May 23, 2017Published: Sep 14, 2017
Est. expiryFeb 14, 2033(~6.6 yrs left)· nominal 20-yr term from priority
Inventors:Qiang CongHeng ChengSanjeev Gangwar
C07K 5/10A61K 38/07C07K 5/06139A61K 47/6861C07K 5/1016C07K 5/06165A61K 47/6857A61K 47/6863A61K 47/6811A61K 47/6869A61K 38/05C07K 7/06A61K 47/64C07K 5/1024A61K 47/6851A61P 35/00C07K 5/06A61K 47/48638A61K 47/48569A61K 47/48246A61K 47/48607A61K 47/48615A61K 47/48592
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Tubulysin compounds of the formula (I) where R 1 , R 2 R 3a , R 3b , R 4 , R 5 , W, and n are as defined herein, are anti-mitotic agents that can be used in the treatment of cancer, especially when conjugated to a targeting moiety.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound having a structure represented by formula (III-13):

Join the waitlist — get patent alerts

Track US2017260232A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.